Anavex Life Sciences Corp (AVXL)

[Biostockclub]

Thanks, Bourbon!

You get it. Missling gets it. AVXL gets it!!

This is not wild nor futuristic. It is sensible and glory be, helpful! And not costly...so it’s no wonder our CEO has reported several times over long periods that we have sufficient cash to cover trials.

Those who cast this as delusional or spin it as an attempt to do “humanless trials” never heard my words (I said “summon a cohort from a database”) which is precisely fact. What would I be suggesting a cohort for if not a trial?!!! If anyone misinterprets, they are either unable to comprehend that, or perhaps working as a “two-ladder truck” to bolster each other while attacking positive news about our company’s approach - intentionally twisting my point. My point was: where the cohort for THE TRIAL CONTAINING REAL LIVE HUMANS would come from. That’s for the record and from the horse’s mouth in case the need to begin twisting arises anew.

Three things cannot be long hidden: the sun, the moon, and the truth.
Buddha

Thanks for the link.

Here are a couple more which delve into the genomics field and a couple of quotes about where this field now stands (extrapolate 5 years later).
Nice to see that the very words Missling said, “enriched trials” are stated in these links, along with, shorter, more accurate, and less costly. All great news for us!


http://genomemag.com/the-changing-face-of-clinical-trials/

And,

The 2 quotes below are from the link which follows.

“This the future way of doing trials in the genomic age,” says Herbst. (2013)

The master protocol trial is set to start in 2014. Its leaders are already anticipating that the new trial design will be applied to other types of cancer and potentially other types of disease.
“I think [the new approach] will result in drugs being much more quickly approved,” says Herbst.

https://www.google.com/amp/s/www.technologyreview.com/s/521496/genomics-could-blow-up-the-clinical-trial/amp/


Thanks for your post!
Bio